Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street

Discover the reasons behind three stocks attracting investor attention as they stand on the precipice of future growth.

Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine

These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot.

The 3 Best Biotech Stocks to Buy in May 2024

If you have the appetite for the risk inherent in the biotech sector, here are three biotech stocks to buy in May.

Earnings Superstars: 3 Stocks Primed to Outperform This Quarter

Discover how Nvidia, Apogee Therapeutics, and JD.com stand out as earnings outperformers in their respective sectors.

Why Is Treace Medical Concepts (TMCI) Stock Down 59% Today?

Treace Medical Concepts stock is falling on Wednesday as investors in TMCI shares react to a poor guidance in its latest earnings report.

Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare

Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because…

Why Is Esperion Therapeutics (ESPR) Stock Up 13% Today?

Esperion Therapeutics stock is up on Tuesday with heavy trading of ESPR shares after the company beat EPS and revenue estimates in Q1.

Why Is Nuvo Group (NUVO) Stock Up 200% Today?

Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger.

3 Biotech Stocks to Double Your Money in the Next 24 Months

The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.

Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back

If you really want to maximize your return potential, then acquiring stocks near 52-week lows could present a viable opportunity. Stated simply, it’s a way…

Why Is Lyra Therapeutics (LYRA) Stock Down 90% Today?

Lyra Therapeutics stock is falling hard with heavy trading on Monday after the company reported a failed Phase 3 clinical trial.

Why Is TC Biopharm (TCBP) Stock Up 51% Today?

TC BioPharm stock is rising higher on Monday with heavy trading of TCBP shares after announcing plans to acquire another biotech company.

Why Is Acutus Medical (AFIB) Stock Down 41% Today?

Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week.

Why Is GlycoMimetics (GLYC) Stock Down 77% Today?

GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.

Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth

With the sharp rise in the equities space since the beginning of the year, it’s been difficult to find undervalued growth stocks. Still, there are…

3 Biotech Stocks With the Potential to Make You an Overnight Millionaire

Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.

Shhh! 3 Secret Robotics Stocks Flying Below Wall Street’s Radar

Highlighting resilience in robotics stocks, Zebra Technologies, Intuitive Surgical and Symbotic embrace AI and forecast impressive gains.

3 Growth Stocks You’ll Kick Yourself for Not Buying Today

Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.

Why Is Vaxxinity (VAXX) Stock Up 39% Today?

Vaxxinity stock is rising higher on Friday with heavy trading of VAXX shares as it remains volatile ahead of its delisting next week.